Can post-polypectomy surveillance be less intensive ?
Menée au Royaume-Uni à partir de données portant sur 11 944 patients présentant des adénomes colorectaux à risque intermédiaire de cancer (durée médiane de suivi : 7,9 ans), cette étude multicentrique évalue le bénéfice, en terme de réduction de l'incidence du cancer colorectal, d'une surveillance médicale par coloscopie
Strong evidence from randomised trials in support of screening led to a consensus in 1997, which resulted in the publication of US guidelines recommending colorectal cancer screening.1 This recommendation resulted in an exponential proliferation of screening programmes with the subsequent identification of large numbers of patients with adenomatous polyps—the most common neoplastic outcome of screening—the removal of which reduces colorectal cancer incidence and mortality.2 The consensus was that, following polypectomy, patients should be placed under surveillance because they were considered to be at increased risk for subsequent adenomas and colorectal cancer.
The Lancet Oncology , commentaire en libre accès, 2016